1115P Comparison of efficacy and toxicity of dabrafenib/trametinib versus vemurafenib/cobimetinib therapy in routine medical practice: Eight years of BRAF/MEK inhibitor use in routine clinical practice
| Autor: | Piejko, K., Cybulska-Stopa, B., Czarnecka, A.M., Ostaszewski, K., Ziętek, M., Galus, L., Bal, W., Kubiatowski, T., Kaminska-Winciorek, G., Suwinski, R., Mackiewicz, J., Dziura, R., Rutkowska, E., Switaj, T., Rogala, P., Kempa-Kaminska, N., Blonski, P., Zielińska, M.K., Rutkowski, P. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S672-S672 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|